My laboratory is focused on understanding how breaks in the genetic material (DNA) can lead to disease. The proposed work will address exciting new hypotheses that have arisen during my current research programme concerning the mechanism/s by which unrepaired DNA single-strand breaks (SSBs), which are breaks in one strand of the DNA double helix, trigger neurodegeneration. To date, six human genetic diseases have been identified in which there is a defect in SSB repair; the latest one being identified under the auspices of my current MRC research programme (spinocerebellar ataxia autosomal recessive 26; SCAR26, which is mutated in the protein, XRCC1). Excitingly, we have discovered how unprepared SSBs trigger this disease, providing not only the first molecular explanation for how SSBs cause disease but also opening up possible new avenues for therapeutic intervention. We plan to pursue these novel discoveries in the new research programme proposed here. We will employ a combination of molecular, cellular, and physiological experimental models to build on our recent discoveries and define at the mechanistic level how SSBs cause defects in neuronal function in vitro and in vivo, and how such defects lead to neurological disease. Importantly, we will also continue to develop our work in a clinical direction, by testing the ability of existing and novel drugs/drug-like molecules for their ability to restore normal neuron function and prevent neurological diseases that arise from SSBs. Whilst we are focusing on experimental models of rare genetic diseases to address our scientific questions, the relevance of this work may extend to more common degenerative diseases and even to the normal ageing population. This is because SSBs are the commonest form of DNA damage arising in cells and are induced not only by oxidative stress (which is elevated in brain and is believed to contribute to human ageing) but as discovered in our recent work also by the normal processes by...
This is one of 1,833 active United Kingdom Research Development opportunities most of your competitors will never see.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start Free| Issuing agency | MRC |
|---|
| Country | United Kingdom |
|---|
| Category | Research Development |
|---|
| Published | April 30, 2022 |
|---|
| Procurement stage | Active solicitation |
|---|
| Response due | April 29, 2027 |
|---|
| Status | Open — accepting responses |
|---|
| Official source | View original notice |
|---|
| Last verified | August 09, 2026 |
|---|
Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.
See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Used by capture teams who win by looking where the big players aren’t.
Get a free United Kingdom Research Development intelligence report in your inbox
A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.